|
US3853893A
(en)
*
|
1973-04-02 |
1974-12-10 |
Squibb & Sons Inc |
Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles
|
|
HU177086B
(en)
*
|
1975-06-09 |
1981-07-28 |
Eszakmagyar Vegyimuevek |
Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives
|
|
JPS58150576A
(ja)
*
|
1982-03-03 |
1983-09-07 |
Sumitomo Chem Co Ltd |
新規な１，２，４−オキサジアゾ−ル誘導体
|
|
DE3247118A1
(de)
*
|
1982-12-20 |
1984-06-20 |
Cassella Ag, 6000 Frankfurt |
Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
US6660753B2
(en)
*
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
EP1582519A3
(en)
*
|
1999-08-19 |
2005-12-21 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
NZ517221A
(en)
*
|
1999-08-19 |
2004-01-30 |
Nps Pharma Inc |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
CN1853630A
(zh)
*
|
2001-02-21 |
2006-11-01 |
Nps制药公司 |
杂多环化合物及其在亲代谢的谷氨酸受体拮抗剂中的应用
|
|
AU2003264018A1
(en)
|
2002-08-09 |
2004-02-25 |
Astrazeneca Ab |
Compounds having an activity at metabotropic glutamate receptors
|
|
WO2004091480A2
(en)
*
|
2003-04-09 |
2004-10-28 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
|
US20060252741A1
(en)
*
|
2003-05-15 |
2006-11-09 |
Colandrea Vincent J |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
|
US20060189661A1
(en)
*
|
2003-11-03 |
2006-08-24 |
Wagenen Bradford V |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2005060961A2
(en)
*
|
2003-12-18 |
2005-07-07 |
Astrazeneca Ab |
Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
|
|
JP4958560B2
(ja)
*
|
2003-12-24 |
2012-06-20 |
プロシディオン・リミテッド |
Ｇｐｃｒ受容体作動薬としてのヘテロ環誘導体
|
|
WO2005077368A2
(en)
*
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
KR20080000622A
(ko)
*
|
2005-04-26 |
2008-01-02 |
뉴로서치 에이/에스 |
신규한 옥사디아졸 유도체 및 이의 의학적 용도
|
|
IL169855A
(en)
*
|
2005-07-25 |
2014-05-28 |
Elta Systems Ltd |
A system and method for locating a receiver location
|
|
AR058439A1
(es)
|
2005-07-26 |
2008-02-06 |
Portela & Ca Sa |
Derivados de nitrocatecol como inhibidores de comt. procesos de obtencion y composiciones farmaceuticas.
|
|
EP1845097A1
(en)
*
|
2006-04-10 |
2007-10-17 |
Portela & Ca., S.A. |
Oxadiazole derivatives as COMT inhibitors
|
|
TWI392671B
(zh)
*
|
2006-09-07 |
2013-04-11 |
Actelion Pharmaceuticals Ltd |
吡啶-４-基衍生物
|
|
ES2400163T3
(es)
*
|
2006-09-08 |
2013-04-08 |
Actelion Pharmaceuticals Ltd. |
Derivados de piridil-3-ilo como agentes de inmunomodulación
|
|
EP2481410B1
(en)
|
2007-01-31 |
2016-07-13 |
BIAL - Portela & Ca., S.A. |
Nitrocatechol derivates as COMT inhibitors administered with a specific dosage regime
|
|
PT2125797E
(pt)
*
|
2007-03-16 |
2014-03-11 |
Actelion Pharmaceuticals Ltd |
Derivados aminopiridina como agonistas do receptor s1p1/edg1
|
|
US8598208B2
(en)
*
|
2007-08-17 |
2013-12-03 |
Actelion Pharmaceuticals Ltd. |
Pyridine derivatives as S1P1/EDG1 receptor modulators
|
|
WO2009108077A2
(en)
*
|
2008-02-28 |
2009-09-03 |
Bial - Portela & Ca., S.A. |
Pharmaceutical composition for poorly soluble drugs
|
|
JP5411877B2
(ja)
*
|
2008-03-06 |
2014-02-12 |
アクテリオン ファーマシューティカルズ リミテッド |
ピリジン化合物
|
|
HRP20130641T1
(en)
*
|
2008-03-07 |
2013-08-31 |
Actelion Pharmaceuticals Ltd. |
Pyridin-2-yl derivatives as immunomodulating agents
|
|
KR20110002462A
(ko)
|
2008-03-17 |
2011-01-07 |
바이알 - 포르텔라 앤드 씨에이 에스에이 |
5-[3-(2,5-디클로로-4,6-디메틸-1-옥시-피리딘-3-일)-[1,2,4]옥사디아졸-5-일]-3-나이트로벤젠-1,2-디올의 결정형
|
|
SI2291080T1
(sl)
|
2008-05-14 |
2015-11-30 |
The Scripps Research Institute |
Novi modulatorji sfingosinskih fosfatnih receptorjev
|
|
WO2010093650A2
(en)
|
2009-02-10 |
2010-08-19 |
Divergence, Inc. |
Compositions and methods for controlling nematodes
|
|
AU2010231961B2
(en)
*
|
2009-04-01 |
2015-05-21 |
Bial - Portela & Ca., S.A. |
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
|
|
RU2550133C2
(ru)
*
|
2009-04-01 |
2015-05-10 |
БИАЛ-ПОРТЕЛА энд КА., С.А. |
Фармацевтические составы, включающие производные нитрокатехола, и способы их получения
|
|
CN102471328B
(zh)
|
2009-07-16 |
2015-04-01 |
埃科特莱茵药品有限公司 |
吡啶-4-基衍生物
|
|
HRP20150919T1
(hr)
|
2011-01-19 |
2015-09-25 |
Actelion Pharmaceuticals Ltd. |
Derivati 2-metoksi-piridin-4-ila
|
|
US20140045900A1
(en)
|
2011-02-11 |
2014-02-13 |
Bial-Portela & Ca, S.A. |
Administration regime for nitrocatechols
|
|
WO2013089573A1
(en)
|
2011-12-13 |
2013-06-20 |
BIAL - PORTELA & Cª., S.A. |
Chemical compound useful as intermediate for preparing a catechol-o-methyltransferase inhibitor
|
|
CA2901006A1
(en)
*
|
2013-02-15 |
2014-08-21 |
Monsanto Technology Llc |
3,5-disubstituted-4,5-dihydro-1,2,4-oxadiazoles for controlling nematode pests
|
|
JP2018500300A
(ja)
|
2014-11-28 |
2018-01-11 |
ノヴィファーマ，エス．アー． |
パーキンソン病を遅延させるための医薬
|
|
BR112017024785B1
(pt)
|
2015-05-20 |
2022-05-17 |
Idorsia Pharmaceuticals Ltd |
Forma cristalina do composto (s)-3-{4-[5-(2-ciclopentil-6-metoxi-piridin-4-il)-[1,2,4] oxadiazol-3- il]-2-etil-6-metilfenoxi}-propano-1,2-diol, composição farmacêutica, e, uso
|